期刊文献+

烧伤脓毒症患者外周C-反应蛋白和CD64水平动态变化 被引量:9

Peripheral C-reactive protein and CD64 level dynamic change in patients with burn and sepsis
下载PDF
导出
摘要 目的探讨早期烧伤脓毒症患者外周C-反应蛋白(C-reactive protein,CRP)和CD64水平动态变化。方法选择我院烧伤科2013-01至2014-01收治的80例烧伤患者,根据是否诊断烧伤脓毒症分为两组,烧伤脓毒症组40例和对照组40例。两组患者入院后及时给予抗生素抗感染治疗,补液抗休克治疗,创面积极换药,保持水电解质平衡等对症支持治疗。对比烧伤脓毒症组和对照组中性粒细胞CD64及CRP水平以及不同烧伤面积患者中性粒细胞CD64及CRP水平。结果烧伤脓毒症组和对照组中性粒细胞CD64分别为(65.2±18.6)%、(16.8±5.7)%,两组CRP水平为(157±34.8)mg/L、(19.6±2.2)mg/L,差异均有统计学意义(P<0.05);烧伤脓毒症组患者(烧伤面积小于60%)和烧伤脓毒症组患者(烧伤面积大于60%)中性粒细胞CD64及CRP水平分别为(46.8±13.5)%、(135.7±32.8)mg/L;(76.9±24.3)%,(189.6±40.5)mg/L,对比差异有统计学意义(t=8.6、7.9,P<0.05)。在烧伤脓毒症时,中性粒细胞CD64的ROC曲线下面积(AUC)最大,优于CRP(P<0.05)。采用约登指数(正确指数=灵敏度+特异度-1)最大值所对应值,得出有意义指标的最佳截断点(cut-off point),得出对CD64、CRP对诊断烧伤脓毒症的灵敏度、特异度、阳性预测值、阴性预测值,结果显示CD64灵敏度、特异度、阳性预测值、阴性预测值均高于CRP(P<0.05)。结论在烧伤伴脓毒症的细菌感染中,CD64具有较高的特异性,其灵敏度、特异度、阳性预测值、阴性预测值均高于CRP。 Objective To study the peripheral C- reactive protein and CD64 level dynamic change in patients with early burn and sepsis. Methods A total of 80 burn patients were collected in this hospital from 2013 January to 2014 January in burn department. According to the diagnosis, they of burn sepsis were divided into 2 groups, burn sepsis group (40 cases) and control group (40 cases ). After admission, two groups of patients were promptly given antibiotics to prevent infection, fluid infusion, anti shock, wound dressing changed actively, maintaining water and electrolyte balance for symptomatic and supportive treatment. Comp Neutrophil CD64 and C- reactive protein (CRP) levels in bum sepsis group and control group were compared and neutrophils level and CD64 and C- re- active protein (CRP) level in patients with different burn area. Results In burn sepsis group and control group, neutrophil CD64 and CRP levels were (65.2 ± 18.6)%, (157 ± 34.8 )mg/L; (16.8 ± 5.7 )% , (19.6 ±2.2 )mg/L, the difference was statistically signif- icant ( t = 12.4, 13.8, P 〈 0.05 ). In bum sepsis group ( patients with burn area of less than 60% ) and burn sepsis patients ( burned area greater than 60% ), levels of neutrephil CD64 and CRP were ( 46.8 ±13.5 ) %, ( 135.7± 32.8 ) nag/L; ( 76.9 ± 24.3 ) % , (189.6 ± 40.5 )mg/L, the difference was statistically significant (t = 8.6, 7.9, P 〈 0.05 ). In burn sepsis, ROC curve area of neu- trophil CD64 (AUC) under the maximum, was better than that of CRP (P 〈 0.05 ). Using Youden index ( the correct index = sensi- tivity + specificity -1 ) corresponding to the maximum value; the optimum truncation points meaningful index (cut-off point), draw on the CD64, CRP sensitivity, in the diagnosis of burn sepsis specificity, positive predictive value and negative predictive value ; the re- sults showed that the CD64 sensitivity and specificity and the positive predictive value and negative predictive value were higher than those of CRP ( P 〈 0.05 ). Conclusions There is a very high specificity of bacterial infection of CD64 on burn with sepsis ;its sensitivity, specificity, positive predictive value, and negative predictive value are higher than CRP.
出处 《武警医学》 CAS 2015年第4期387-390,共4页 Medical Journal of the Chinese People's Armed Police Force
关键词 烧伤 脓毒症 C-反应蛋白 CD64 烧伤面积 CD64 burn sepsis C- reactive protein CD64 burn area
  • 相关文献

参考文献17

  • 1Luzzani A,Polati E, Dorizzi R, et al. Comparison of CD64 and C -reactive protein as markers of sepsis [ J ]. Crit Care Med,2014,8(27) :1-8.
  • 2Vasil B, Antonovic O. The serum level of C -reactive protein inneonatal sepsis [ J]. Srp Arh Celok Lek,2013, 12(33) :1774-1777.
  • 3Kumar V, Mohanty M K, Kanth S. Fatal bums in Mani- pal area a 10 year study [J]. Forensic LegMed,2012, 50( I ) :94-100.
  • 4Sandri M T, Passerini R, Leon M E, et al. CD64 as a useful marker of infection in hema to cological patients with fever [ J ]. Anticancer Res, 2012, 78 ( 11 ) :427-430.
  • 5吴其夏,余应年,卢建.新编病理生理学[M].北京:中国协和医科大学出版社,2014:220-223.
  • 6Nakanishi K, Takeda S, Sakamoto A, et al. Effects of Ulinastatin treatment on the cardiopulmonary bypass in- duced hemodynamic in stability and pulmonary dysfunc- tion [J]. Crit Care Med,2012,78(11) :427-430.
  • 7杭永伦,蔡美珠,杨平.烧伤患者四种急性时相蛋白检测的临床价值[J].中国实用内科杂志,2013,32(4):229-230.
  • 8汤学民,马江涛,王元彬.589例超敏C-反应蛋白检测结果的临床分析[J].实用医技杂志,2006,13(2):182-183. 被引量:4
  • 9方德洋,李正花,赵春青.血浆D-二聚体和纤维蛋白原在重度烧伤患者中的表达及临床意义[J].中国误诊学杂志,2008,8(3):563-564. 被引量:11
  • 10Tsujino T, Komatsu Y, Isayama H, et al. Ulinastatin for pancreatitis after endoscopic retrograde cholan giopan- crea to graphy a randomized controlled trial[ J]. N Engl J Med,2013,332(24) :767-773.

二级参考文献126

  • 1柴家科,盛志勇.应重视严重烧伤脓毒症患者骨骼肌蛋白高分解代谢的研究[J].中华医学杂志,2005,85(41):2883-2885. 被引量:16
  • 2谢康,黄跃生,安瑞,周军利,张家平.乌司他丁对严重烧伤患者伤后早期心肌损害的防治作用[J].中华烧伤杂志,2006,22(3):180-183. 被引量:32
  • 3刘芳,翟所迪,田荣萍.临床应用人血白蛋白的循证医学评价[J].中国药学杂志,2007,42(6):478-480. 被引量:46
  • 4Klein MB, Edwards JA, Kramer CB, et al. The beneficial effects of plasma exchange after severe burn injury [ J ]. J Burn Care Res, 2009,30(2) :243 -248.
  • 5Park JH, Kwak SH, Jeong CW, et al. Effect of ulinastatin on cytokine reaction during gastrectomy [ J ]. Korean J Anesthesiol, 2010,58(4) :334 -337.
  • 6刘世康,方之扬.烧伤后播散性血管内凝血.黎鳌.烧伤治疗学[M].2版.北京:人民卫生出版社,1995:115-116.
  • 7Turgut U,Huseyin S. Looking for our ten years results for coronary heart disease and ischecnic storke group for the standpoint of haemostasis [J]. Turk J Haematol, 2002,19 (2) : 255-263.
  • 8Monye W, Sanson BJ, Bullet HR,et al. The performance of two rapid quantitative D dimer assays in 287 patients with clinically suspected pulmonary embolism[J]. Thromb Res, 2002,107: 283- 286.
  • 9Q uinlan GJ, Martin GS, Evans TW. Albumin: biochemical properties and therapeutic potential[J]. Hepatology, 2005, 41(6): 1211-1219.
  • 10Droge W. Aging-related changes in the thiol/disulfide redoxstate: implications for the use of thiol antioxidants[J]. Exp Gerontol,2002,37(12): 1333-1345.

共引文献70

同被引文献113

  • 1赵丽丽,张立明,王润秀,蒙诚跃,欧斌贤.烧伤感染患者外周血CD64、C-反应蛋白的表达及其临床意义[J].中国现代医药杂志,2012,14(4):9-11. 被引量:2
  • 2Martin GS, Mannino DM, Eaton S, et al. The epidemiology of sepsis in the United States from 1979 through 2000 [ J]. N Engl J Med, 2003,348 ( 16 ) : 1546-1554.
  • 3Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States : analysis of incidence, outcome, and associated costs of care [J]. Crit Care Med,2001,29(7) : 1303-1310.
  • 4Otero RM, Nguyen HB, Huang DT, et al. Early goal-directed therapy in severe sepsis and septic shock revisited: concepts, controversies, and contemporary findings [ J ]. Chest, 2006, 130 (5) :1579-1595.
  • 5Peters RP,van Agtmael MA,Danner SA,et al. New developments in the diagnosis of bloodstream infections [J]. Lancet Infect Dis, 2004,4(12) :751-760.
  • 6Henriquez-Camacho C, Losa J. Biomarkers for sepsis. Biomed Res Int [ J] ,2014,2014:547818.
  • 7Waeker C, Prkno A, Brunkhorst FM, et al. Proealcitonin as a diagnostic marker for sepsis : a systematic review and meta-analysis [ J]. Lancet Infect Dis,2013,13 (5) :426-435.
  • 8Bloos F, Reinhart K. Rapid diagnosis of sepsis [ J ]. Virulence, 2014,5 ( 1 ) : 154-160.
  • 9Repp R, Valerius T, Sendler A, et al. Neutrophils express the high affinity receptor for IgG (Fc gamma RI, CI)64 ) after in vivo application of recombinant human granulocyte colony-stimulating factor [ J]. Blood, 1991,78 (4) :885-889.
  • 10van der Meet W, Piekkers P, Scott CS, et al. Hematological indices, inflammatory markers and neutrophil CD64- expression: comparative trends during experimental human endotoxemia [J]. J Endotoxin Res ,2007,13 ( 2 ) :94-100.

引证文献9

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部